Provider review
Alloy review
Writes the addition out — a care fee plus medication, both in the same sentence.
Built by menopause-specialized physicians, and one of the few sellers publishing its own material on holding a small dose.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Alloy
$99/mo care + med from $70/mo — two charges, not one
- Vs median
- Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Two things make this row worth reading even though its price cannot enter a comparison. The first is the arithmetic, which Alloy performs in public. Most sellers with a care fee and a medication charge print the smaller one large and leave the addition to be discovered at checkout; this one puts both figures in the same sentence, twice, and repeats the medication caveat in the discount copy. The floor is therefore knowable before signing up, which is more than most of the category manages, and it is also higher than the headline suggests. The second is who the care is built for. The clinicians are menopause specialists rather than generalists, the copy is explicit that midlife weight change has hormonal causes standard programs ignore, and the company publishes its own explainer on holding a deliberately small GLP-1 dose during menopause — an unusually direct engagement with the question this page exists to answer. Against that, the medication figures are all floors with no milligram behind them, so what a low dose costs is still unanswerable. The branded line is priced too, which is rare and useful: you can see what an FDA-approved product costs here against the compounded alternative, and one of those branded figures is shown struck through from a much larger number.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You are in midlife and want clinicians who treat that as the cause rather than an aside
- You want both halves of the bill printed before you sign up rather than after
- You want branded and compounded options priced on the same page so you can weigh them
Look elsewhere if
- You are comparing single monthly figures. Here there are two charges, and both matter
- You want to know what your dose costs. Every medication figure is a floor with no milligram
- You are budgeting the first month off the discount code. It applies to the care fee only
What it actually costs
Price as published
The published figure is half the bill, and the page says so plainly: "Alloy Weight Care is $99/month plus the cost of medication. Medication starting at $70/month" — so the real floor is the two added together · the medication side is itemized properly: compounded semaglutide from $70/mo, compounded tirzepatide from $100/mo, compounded liraglutide from $115/mo, alongside branded Zepbound from $299/mo, Zepbound KwikPen from $299/mo, Wegovy Pen from $199/mo shown struck through from $499, Wegovy Pill from $149/mo and Foundayo Pill from $149/mo · a $50 code takes the first month of the care fee off, medication excluded · every medication figure is a "starting at" and no dose sits behind any of them, though the compounded line is described as "personalized dosing for gentler starts" · care is delivered by menopause-specialized physicians with unlimited messaging, and the company publishes its own explainer on microdosing GLP-1s during menopause
- Vs median
- Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. The published figure is half the bill and the page performs the addition itself — a monthly care fee plus medication, both printed in the same sentence. That makes the floor knowable, which most stacked sellers do not manage, and it also means no single number here can be set against a one-charge plan elsewhere. ★ The care is delivered by menopause-specialized physicians and the company publishes its own material on holding a small GLP-1 dose through menopause, which is a more direct engagement with this question than almost anything else here. Three compounded molecules and five branded products are itemized, including oral tablets, but every medication figure is a floor with no dose behind it and no low-dose product is sold. It also sells compounded liraglutide, priced per month like the other two and subject to the same care fee on top.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Both halves of the bill are printed in the same sentence rather than discovered later.
- Three compounded molecules and five branded products are itemized with their own figures.
- Care is delivered by menopause-specialized physicians with unlimited messaging included.
Pharmacy, labs and oversight
Alloy does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Alloy publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Two things make this row worth reading even though its price cannot enter a comparison. The first is the arithmetic, which Alloy performs in public. Most sellers with a care fee and a medication charge print the smaller one large and leave the addition to be discovered at checkout; this one puts both figures in the same sentence, twice, and repeats the medication caveat in the discount copy. The floor is therefore knowable before signing up, which is more than most of the category manages, and it is also higher than the headline suggests. The second is who the care is built for. The clinicians are menopause specialists rather than generalists, the copy is explicit that midlife weight change has hormonal causes that standard programs ignore, and the company publishes its own material on holding a deliberately small GLP-1 dose during menopause — which is an unusually direct engagement with the question this site exists to answer. Against that, the medication figures are all floors with no milligram behind them, so what a low dose costs is still unanswerable from the page. The branded line is priced too, which is rare and useful: a reader can see what an FDA-approved product costs here against the compounded alternative, and one of those branded figures is presented struck through from a much larger number.
The honest cons
The headline figure is the care fee only; medication is charged on top of it.
- Every medication figure is a starting point with no dose attached to it.
- The first-month discount applies to the care fee, not to the medication.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Alloy is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#236 of 373
Ordered with the companies that pay us first, and Alloy is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- What the evidence actually shows
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.